Abstract: To characterize rectal histology in an inception cohort of children newly diagnosed with ulcerative colitis (UC) and to explore its relationship with clinical indices of disease severity. The PROTECT (Predicting Response to Standardized Pediatric Colitis Therapy) Study enrolled children 17 years of age and younger newly diagnosed with UC. Baseline rectal biopsies were evaluated for acute and chronic inflammation, eosinophilic inflammation (peak eosinophil count > 32 eosinophils/high powered field, eosinophilic cryptitis or abscesses), and architectural/nonarchitectural chronic changes. Correlation with clinical indices including Mayo endoscopy subscore and Pediatric Ulcerative Colitis Activity Index was performed. Rectal biopsies from 369 patients (mean age, 12.9 ± 3.1 y, 50% female) were reviewed. Cryptitis was found in 89%, crypt abscesses in 25%, and eosinophilic inflammation in 58%. Crypt distortion/atrophy was present in 98% of specimens. Higher grades of acute and chronic inflammation were associated with the presence of basal plasmacytosis (P < 0.0001), basal lymphoid aggregates (P < 0.0001), and surface villiform changes (P < 0.0001). A severe Mayo endoscopy subscore was most common among those with severe acute and chronic inflammation, although this relationship was not linear. Severe Pediatric Ulcerative Colitis Activity Index scores were associated with the absence of or only mild eosinophilic inflammation (< 32 eosinophils/high powered field) (P < 0.03) and the presence of surface villiform changes (P < 0.005). Acute and chronic inflammation, eosinophilic inflammation and chronic changes are common in children newly diagnosed with UC. The clinical and biological implication of low to absent eosinophilic inflammation and the presence of surface villiform changes requires further study.
U lcerative colitis (UC) is a chronic inflammatory disorder manifested by signs and symptoms of colonic dysfunction, mucosal abnormalities demonstrated at endoscopy, and mucosal biopsies that generally confirm active inflammation. 1, 2 However, the classic histologic signs of chronicity such as crypt architectural distortion, reduced crypt density and basal plasmacytosis may be less commonly identified in colon biopsies of children compared with adults with UC, [2] [3] [4] [5] [6] especially in those children under the age of 10 years. 5 Lack of chronic histologic changes can impact the ability to distinguish UC from acute self-limited colitis. [3] [4] [5] Histologic findings in UC may include increased eosinophils raising the specter of an alternative diagnosis such as eosinophilic or allergic colitis. [3] [4] [5] 7, 8 Systematic evaluations of eosinophilic infiltrates have not always been reported in previous studies of children suspected to have UC. 4, 5 Eosinophils may be more numerous in biopsies from pediatric patients with UC compared with biopsies from patients with allergic conditions. 8 Clinical and experimental evidence suggests an important role for eosinophils in colitis: the chemokine eotaxin-1 which promotes eosinophil infiltration into tissue is increased in both gene array and polymerase chain reaction studies in rectosigmoid biopsies from children who have UC, and eotaxin-1 and eotaxin-2 levels, and eosinophil density are increased in the colon of mice following dextran sodium sulfate-induced epithelial injury. 9 Eosinophils in colonic biopsies from children [10] [11] [12] [13] are least numerous in the rectosigmoid colon compared with the more proximal colon and can be present in surface and crypt epithelium in normal biopsies. 10, 12 Applying quantitative criteria to identify increased eosinophil density and eosinophilic cryptitis/abscess would aid in the ability to identify biopsies with excess eosinophils in clinical practice with more certainty, and could define more specifically the correlations between eosinophil density and endoscopic and clinical features of UC.
The PROTECT Study: Predicting Response to Standardized Pediatric Colitis Therapy was initiated in 2012 to systematically examine the response of children and adolescents newly diagnosed with UC to standardized treatment regimens. During this prospective study a large inception patient cohort was rigorously phenotyped clinically, endoscopically, and histologically. We now report the histopathologic findings from the treatment naive PROTECT patient cohort determined by centralized reading of rectal biopsies obtained at the time of the clinical diagnosis. The goals of our study were to evaluate the relationship of inflammatory and architectural changes to clinical presentation heretofore reported in smaller single center studies and to further explore the relationship of eosinophilic infiltrates to histologic, clinical, and endoscopic findings.
METHODS

Patient Population
Potential patients for inclusion in the PROTECT study were recruited from 29 participating centers. Children between the ages of 4 and 17 years with a clinical history suggestive of UC (eg, any combination of diarrhea, bleeding, and abdominal pain) were eligible. Complete demographic, clinical, and endoscopic data by ileocolonoscopy and esophagogastroduodenoscopy were obtained. Eligibility required disease extent beyond the rectum only (patients with proctitis only by endoscopic assessment were excluded), a baseline Pediatric Ulcerative Colitis Activity Index (PUCAI) 14 score of ≥ 10, no previous therapy for colitis, and stool testing negative for enteric bacterial pathogens (Salmonella, Shigella, Campylobacter, Escherichia coli 0157:H7) and Clostridium difficile toxin. A clinical, endoscopic, and histologic diagnosis of UC was made using previously established criteria. 1 Disease extent was classified as proctosigmoiditis, left-sided (to the splenic flexure), extensive (to the hepatic flexure), and pancolitis (to the cecum). Visual endoscopic evidence of inflammation was used to determine disease extent and severity of endoscopy findings was recorded as Mayo endoscopic subscore (MSS) 15 according to a referenced 4-point pictorial scale system (0 inactive, 1 mild, 2 moderate, 3 severe) provided to all sites. The MSS was determined by the endoscopist at each participating site. Disease severity by PUCAI was scored over a range of 0 to 85. Mild PUCAI scores ranged from 10 to 34, moderate PUCAI ranged from 35 to 64 and severe PUCAI scores were ≥ 65. 14 Patients with clinical, endoscopic, radiologic, or histologic evidence of Crohn disease, use of oral corticosteroid for nongastrointestinal indications in the past 4 weeks, other gastrointestinal or nongastrointestinal conditions which could interfere with the study mandated therapy (ie, active medical or surgical disease or active liver/gastrointestinal disease) or positive testing for enteric bacterial pathogens were excluded.
Histologic Assessment
Patients enrolled in the PROTECT study could have rectal biopsy specimens collected at diagnosis and sent for central review. Each patient with rectal biopsies available for central review was included in this histologic substudy. An experienced pediatric pathologist (M.H.C.) examined these de-identified rectal biopsies and recorded findings on a standardized form. The additional rectal biopsy obtained for central review was fixed in formalin, routinely processed in the central review pathology laboratory, and embedded in paraffin blocks from which 4 to 5 µm sections were cut and stained with hematoxylin-eosin. Two to 3 levels were examined on 1 slide per biopsy.
Validated histopathologic scoring systems to evaluate baseline rectal biopsies from children with UC do not exist. In order to evaluate the character of the inflammatory infiltrate including quantitative evaluation of eosinophils and chronic changes at baseline, a scoring system was devised for the PROTECT study ( Table 1) . Grades of acute and chronic inflammation were recorded on a 5-point scale as I= no acute inflammation and no increase in chronic inflammation; II = chronic inflammation only; III = acute inflammation including acute cryptitis but without crypt abscesses; IV = acute inflammation including crypt abscesses in ≤ 10% of crypts; and V = acute inflammation including crypt abscesses in > 10% of crypts. These grades were combined into 3 groups for subsequent statistical analysis (grades I/II, grade III, and grades IV/V). A crypt abscess was defined as a damaged crypt that was dilated and lined by attenuated epithelium with reduced to absent mucin and acute inflammation in the pericryptal lamina propria, in the damaged crypt epithelium and in the crypt lumen (Figs. 1, 2) .
Criteria to evaluate eosinophil density in rectal biopsies were based upon a previous study describing the presence of eosinophils in normal biopsies from children. These criteria are used in routine clinical practice by the central pathology reviewer. 10 Eosinophil density was based on a peak eosinophil count. Grade 1 applied to specimens with ≤ 32 eosinophils per high power field (hpf); grade 2 included specimens with > 32/hpf. Intraepithelial eosinophils were also scored, and grade 3 eosinophil inflammation was eosinophilic cryptitis ( > 9 intraepithelial eosinophils/hpf); grade 4 eosinophil inflammation was with eosinophil abscesses in ≤ 10% of crypts; and grade 5 eosinophil inflammation was eosinophil abscesses in > 10% of crypts.
Chronic architectural/nonarchitectural features were scored in a dichotomous manner as present or absent. These features were ulcer/erosion defined as the absence of surface epithelium with granulation tissue (ulcer) or disrupted/absent surface epithelium with fibrin deposits (erosion); crypt distortion/atrophy defined broadly as crypt abnormalities including elongated crypts, branched crypts, atrophic crypts; surface villiform changes defined as villiform changes at the surface; basal plasmacytosis defined as aggregates of plasma cells below crypts and above the muscularis mucosa; basal lymphoid aggregates defined as aggregates of lymphocytes below crypts and above the muscularis mucosa; Paneth cell metaplasia defined as Paneth-like cells in crypt epithelium; and granulomas defined as sarcoid-like granulomas in mucosa that was not inflamed (pericryptal granulomas in areas of crypt inflammation/damage were excluded from the definition of sarcoid-like granulomas). Some features required good tissue orientation for evaluation; a category of not evaluable was created for ulcer/erosion, surface villiform changes, basal plasmacytosis, and basal lymphoid aggregates for biopsies that were not well-oriented and in which those features could not be reliably evaluated. Therefore the denominator could differ between each type of architectural/nonarchitectural change.
Statistical Approach
Demographic, clinical indices, and central biopsy data were reported as summary statistics. Central biopsy data were further grouped into acute and chronic inflammation, eosinophilic inflammation and chronic architectural and nonarchitectural changes. The χ 2 test/ Fisher exact tests were used for categorical data and the t test was used for continuous data. Spearman correlation was used to compare peak biopsy eosinophil count to total serum eosinophil count. A P-value of <0.05 was considered significant.
Ethical Standards and Manuscript Preparation
Informed consent/assent was obtained in all cases and the study was approved by the local investigational review board at all investigative sites. This study was registered with clintrials.gov (NCT01536535). The manuscript was written by the PROTECT Study Publication committee and subsequently approved by all authors.
RESULTS
A total of 431 subjects were enrolled in PROTECT with 369 (86%) having rectal biopsy material for review. The mean patient age was 12.9 ± 3.1 years, 50% of subjects were female and 112/369 (30%) were younger than 12 years of age. The extent of disease at diagnosis was evaluable in 346/369 (94%) of patients, while 23/369 (6%) had incomplete colonoscopies. Extensive/pancolitis was observed in 76%, 11% had left-sided colitis, and 7% proctosigmoiditis. Clinical scoring by the MSS was evaluable in 368/369 and by the PUCAI in all 369 patients. Demographic and clinical characteristics of the study population are shown in Table 2 .
Grades of Acute and Chronic Inflammation
Grades of acute and chronic inflammation are shown in Table 2 . Cryptitis was found in 238/369 (65%) of specimens while 25% (92/369) had crypt abscesses. Grades of acute and chronic inflammation did not differ by age (younger than 12 vs. 12 y and older), sex, race, or presenting symptoms (diarrhea, abdominal pain, or rectal bleeding).
Eosinophilic Inflammation
There were 206/369 (56%) biopsies that contained > 32 eosinophils/hpf (grade 2) but without excess intraepithelial eosinophils. Only 8/369 (2%) biopsies had eosinophilic cryptitis or eosinophilic crypt abscesses (grade 3 or 4) ( Table 2 ). The mean peak eosinophil count was 41.6 ± 30/hpf. Eosinophil density was similar regardless of age, sex, race, disease location, or presenting symptoms. There was no relationship between the absolute eosinophil count in the serum complete blood count and the biopsy eosinophil count (P = 0.16).
Chronic Architectural/Nonarchitectural Changes
Crypt atrophy/distortion was nearly universal occurring in 98% of specimens while ulceration/erosion was uncommon, being found in just 4% of biopsy specimens. A summary of the presence of each type of architectural/nonarchitectural change is shown in Table 2 .
Relationship Between Grades of Acute and Chronic Inflammation and Eosinophilic Inflammation
The relationship between grades of acute and chronic inflammation and eosinophilic inflammation is shown in Values are presented as counts and percentages in parenthesis. *Mean ± SD. †Eight patients with missing race data. ‡Total "n" in each domain differs related to missing data or inability to evaluate that feature of the biopsy specimen.
§One patient with missing MSS data. Table 3 . The distribution of eosinophilic inflammation across the degrees of acute and chronic inflammation was found to be similar (P = 0.10).
Relationship Between Grades of Acute and Chronic Inflammation or Eosinophilic Inflammation and Chronic Architectural/ Nonarchitectural Changes
The distribution of architectural/nonarchitectural changes differed across the grades of acute and chronic inflammation for surface villiform changes (P < 0.001), basal plasmacytosis (P < 0.0001), and basal lymphoid aggregates (P < 0.0001) ( Table 4 ). Among those specimens with grade IV/V inflammation, 47/91 (52%) had surface villiform changes, 56/84 (67%) had basal plasmacytosis, and 64/84 (76%) had basal lymphoid aggregates.
The distribution of architectural/nonarchitectural changes also differed across degrees of eosinophilic inflammation for basal plasmacytosis (P = 0.004), basal lymphoid aggregates (P = 0.0003), and surface villiform changes (P = 0.03) ( Table 4 ). The presence of each of these architectural/nonarchitectural changes was more common in those with grade 2, 3 or 4 eosinophilic inflammation compared with those with grade 1 (Table 4) .
Relationships Between Degrees of Acute and Chronic Inflammation or Eosinophilic Inflammation and MSS
The relationship between grades of acute and chronic inflammation and MSS are shown in Table 5 and Figure 3 . The distribution of MSS differed across grades of acute and chronic inflammation (P < 0.03). However, this relationship was not linear as demonstrated by the fact that among those with the most severe acute and chronic inflammation (grade IV/V), 51% had MSS 2 compared with 40% with MSS 3 (Table 5 ). However, the percentage of patients with a MSS of 3 increased from 26% among those with grade I/II, to 32% in grade III, and 40% in those with grade IV/V.
The distribution of eosinophilic inflammation also differed across the MSS (P = 0.007). A MSS of 3 was more common in those with absent or reduced eosinophilic inflammation (grade 1) at 39% compared with 30% of those with grades 2, 3 or 4 having a MSS of 3 (Table 5 ). Values are presented as counts and percentages in parenthesis.
Relationship Between Chronic Architectural/ Nonarchitectural Changes and MSS
The distribution of architectural/nonarchitectural changes differed across MSS for surface villiform changes (P = 0.007), basal plasmacytosis (P = 0.0009), and basal lymphoid aggregates (P = 0.01) ( Table 6 ).
Relationships Between Degrees of Acute and Chronic Inflammation or Eosinophilic Inflammation and PUCAI Scores
The relationship between grades of acute and chronic inflammation and clinical disease activity by PUCAI scores are noted in Table 7 and Fig. 4 . This distribution differed across PUCAI scores (P < 0.002). The percentage of patients having severe PUCAI scores increased from 13% in those with grade I/II, to 31% in grade III, and 42% in grade IV/V. However, this relationship was not linear and among those with the most severe acute and chronic inflammation grade IV/V, 42% had severe while 46% had moderate PUCAI scores.
The distribution of eosinophilic inflammation also differed across PUCAI scores (P < 0.007). Among those with reduced or absent eosinophilic inflammation (grade 1), 40% had severe PUCAI scores compared with just 26% of those with grade 2, 3, or 4 eosinophilic inflammation.
Relationship Between Chronic Architectural/ Nonarchitectural Changes and PUCAI Scores
The distribution of surface villiform changes differed across PUCAI scores (P < 0.005) ( Table 8 ). Among those with severe PUCAI scores, 44% (51/117) had surface villiform changes compared with 40% (67/167) of those with moderate PUCAI scores. Surface villiform changes were least common in those with mild PUCAI scores.
There was a trend toward higher rates of severe PUCAI scores in those with basal plasmacytosis (P = 0.06) though not statistically significant. There was no association between basal lymphoid aggregates or Paneth cell metaplasia and clinical severity.
DISCUSSION
This study provides a comprehensive review of the clinico-histopathologic manifestations of treatment naive pediatric UC. Novel data that we report are relationships between grades of acute and chronic inflammation, eosinophil density, and chronic architectural and nonarchitectural abnormalities with clinical and endoscopic findings.
Our study greatly expands knowledge of eosinophil density and associated findings identified in baseline rectal biopsies of children newly diagnosed with UC. We found that eosinophilic inflammation was common with 56% of patients having mucosal eosinophilia. The mean peak number of eosinophils in our study was 41.6 ± 30/hpf. This expands upon prior smaller single-center studies describing the presence of mucosal eosinophilia in children with Inflammatory bowel disease (IBD). [7] [8] [9] The clinical significance of mucosal eosinophilia in IBD remains uncertain. A recent study designed to identify predictors of colectomy and failure of medical therapies in adults suggested that the absence of eosinophils may be associated with need for colectomy. 16 Our study found that features of chronic change including basal plasmacytosis, basal lymphoid aggregates, and surface villiform changes were found more commonly in subjects who had greater density of eosinophils in rectal biopsies compared with those who had the expected peak count. Our data also elucidate the frequency of common architectural/nonarchitectural changes at the time of diagnosis. The frequency of these chronic changes described in previous studies has been inconsistent, with chronic changes ranging from 8% to 32%. 3, 4 Glickman et al 4 described 18% of rectal biopsies that lacked architectural changes. In contrast, a study by Robert et al 5 found 100% of patients had chronic architectural changes in the rectal biopsies. Consistent with this latter study, we found that 98% of rectal biopsies showed crypt architectural distortion. Our findings expand the understanding of the presence of Paneth cell metaplasia. A small, single-center study by Simmonds et al 17 found that Paneth cell metaplasia was found in the distal colon in 85% of children with IBD (UC and Crohn disease) while it was absent in age-matched healthy controls. In contrast, we found Paneth cell metaplasia to be uncommon, identified in only 8% of rectal biopsies. Although the Simmonds' study included multiple biopsies from rectum and more proximal colon compared with a single rectal biopsy collected for PROTECT, our study included substantially more total biopsies and may therefore be a truer estimate of the actual incidence of Paneth cell metaplasia.
We found that the presence of surface villiform changes, basal plasmacytosis, and basal lymphoid aggregates was associated with more severe grades of acute and chronic inflammation. This relationship between the presence of basal plasmacytosis at diagnosis and future clinical outcomes may be of particular importance. Prior studies in adults with IBD have shown that the presence of basal plasmacytosis in biopsies of patients in clinical and endoscopic remission was predictive of subsequent clinical relapse within the subsequent 12 months. 18 Future studies from our PROTECT cohort will evaluate if the presence of basal plasmacytosis identified at diagnosis could be associated with poorer clinical outcomes.
Our study also expands upon the relationship between histologic changes and clinical indices of severity. We found that these relationships are not linear but rather more severe histologic inflammation did not correlate with more severe endoscopic sub-scores (MSS). Clinical severity as captured by PUCAI scores did increase as the grades of acute and chronic inflammation increased, yet a moderate PUCAI score was found most commonly even among those with the most severe acute and chronic inflammation. In contrast, we found that a reduction or lack of eosinophilic inflammation (grade 1) was most commonly seen in those with severe PUCAI scores, suggesting that a lack of eosinophil density in rectal biopsies may correlate with more severe clinical phenotypes of UC. In addition, the presence of surface villiform changes differed across PUCAI scores. We found that the percentage of specimens with surface villiform changes was greatest in those with severe PUCAI scores. Future studies analyzing histologic data from the PROTECT cohort will assess the impact of these baseline findings upon future clinical outcomes.
Strengths of our study include the large number of patients included, standardized method of capturing and reporting the findings, and the inclusion only of patients with newly diagnosed and untreated UC. The primary limitation of our study is the availability of a single biopsy for central review. However, this limitation is similar to limitations in prior studies evaluating baseline histologic changes in pediatric UC. Washington et al's 3 study also analyzed only one rectal biopsy and the correlation between the findings of 2 pathologists was not described. In a subsequent study, individual pathologists reviewed biopsies from multiple areas of the colon, yet group review was performed only in cases of uncertainty. 4 In conclusion, acute and chronic inflammation, eosinophilic inflammation, and chronic architectural/nonarchitectural changes are common in the rectal biopsies of a large, wellcharacterized population of pediatric UC patients before therapy. Low eosinophil counts (< 32 eosinophils/hpf) as well as surface villiform changes are associated with severe clinical disease as determined by PUCAI scores. These data lay the foundation for future studies investigating how different biological pathways contribute to the histopathologic expression of pediatric UC. 
